… proven track record in scaling biotech companies, combined with deep financial … . (acquired by Amgen Inc.), and Human Genome Sciences Inc. (acquired by GSK plc …

… Journey through 50 Years of Biotechnology, modern biotechnology really began with the … written in Genetic Engineering & Biotechnology News (GEN) that they experienced … Haseltine at the helm of Human Genome Sciences to commercialize TIGR’s findings …

… Therapeutics plc) Biogen Inc. GlaxoSmithKline (Human Genome Sciences, Inc.) Pfizer Inc. Takeda Pharmaceutical … -416-8900 KEYWORD: INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH NEUROLOGY SOURCE: Research …

… API for the pharmaceutical and biotech sectors, announced the appointment of … director of process development at Human Genome Sciences (later acquired by GSK), Otsuka …

Flashpoint Therapeutics, a clinical-stage biotechnology company developing precision-engineered structural … his previous leadership positions at Human Genome Sciences, Bristol Myers Squibb, and Abbott …

… Therapeutics, a clinical-stage biotechnology company developing a new … at Immunex, 3M Pharmaceuticals, Human Genome Sciences, Emergent BioSolutions, Bristol Myers … RESEARCH MEDICAL DEVICES NANOTECHNOLOGY BIOTECHNOLOGY HEALTH PHARMACEUTICAL SCIENCE ONCOLOGY …

… members of the iShares Biotechnology ETF (IBB). Saving … South San Francisco-based biotechnology startup Genentech together to … Haseltine, former CEO of Human Genome Sciences, said in a Science … engine to fuel the biotechnology industry, leading many mergers …

… who has built numerous biotechnology companies creating extensive … Aventis (now Sanofi), Pfizer, Human Genome Sciences (now GSK) and Biogen … 47;company/interax-biotech | www.interaxbiotech.com … interaxbiotech.com SOURCE: InterAx Biotech AG   View source …